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ABSTRCT
This thesis proposes a mechanism for the induction of
peripheral tolerance to protein antigens. I have investigated the
mechanism of tolerance induction to soluble protein antigens by
targeting an antigen to small , resting B cells. For this purpose I have
used a rabbit antibody directed at the IgD molecule found on the
surface of most small, resting B cells but missing or lowered on
activated B cells. Intravenous injection of normal mice with 100 
of an ultracentrifuged Fab fragment of rabbit anti -mouse IgD (Fab
anti-8) makes these mice profoundly tolerant to challenge with
nonimmune rabbit Fab (Fab NRG) fragments. This tolerance is
antigen specific since treated mice make normal responses to an
irrelevant antigen, chicken immunoglobulin (Ig). Fab fragments of
rabbit Ig (rabbit Fab) not targeted to B cells do not induce tolerance
as well as Fab anti- Evidence suggests that the B cells must remain
in a resting state for tolerance to be induced, since injection of F(ab)'2
anti-8 does not induce tolerance. Investigation of the mechanisms of
the tolerance, by adoptive transfer, have shown that rabbit Fab
specific B cell function has been impaired. The major effect however
is in helper T cell function, as shown by adoptive transfer and lack of
hel,p for a hapten response. In vitro proliferation experiments show
that the T cell response has not been shifted toward activation of
different T cell subsets which do not help Ig production, nor is there
any change in the Ig isotypes produced. Suppression does not
appear to be the major cause of the helper T cell defect as shown by
cell mixing experiments. This work shows that an antigen targeted
to small B cells can induce tolerance to a soluble protein antigen, and
suggests a role for small B cells in tolerance to self-proteins not
presented in the thymus.
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CHAPTR I.
INODUCTON
This thesis will investigate the role of small cells as antigen
gresenting cells in tolerance induction. I will introduce here the
interactions of T cells, B cells and other antigen presenting cells
(APCs), how tolerance is generated in the thymus, why peripheral
tQlerance is required, the role of APCs, the difference between
ffective and ineffective antigen presentation, and the consequences
of ineffective antigen presentation. I will also give an overview of
acquired tolerance to soluble protein antigens and the mechanisms
p,oposed to mediated this tolerance. I will then describe why I
think that small B cells are the APC in the induction of acquired and
self tolerance to peripheral antigens.
Overview of the Immune Response.
The immune system contains two antigen specific cell types , T
lymphocytes and B lymphocytes, which interact with a variety of
other cell types including macrophages (M ) and dendritic cells.
Each 'mdividual T or B cell is unique because it bears on its surface an
individually rearranged antigen receptor which recognizes particular
Sites (epitopes) found on antigens (1). Upon antigen recognition
these cells interact to produce an immune response which may take
one of several forms: antibody mediated, cell mediated, or cytotoxic.
The type of the response is regulated by the location of the antigen
in the body, the type of APC which picks up the antigen (B cell, M~
or dendritic cell), the !ype of help provided by specific cytokines, and
by the antigen itself and its form (2, 3).
An antibody response is produced by lymphocytes. B cells
are derived from bone marrow precursor cells and express on their
surface Ig molecules, which are identical in their variable regions to
the Ig that the B cell will secrete upon activation.
serves as the antigen receptor on lymphocytes.
This Ig molecule
Some antigens
(particularly carbohydrates and other molecules having repeating
subunits) are able to extensively cross-link these Ig molecules on the
B cell and activate the B cell to grow and differentiate into Ig
secreting plasma cells without the help of antigen-specific T cells.
However, most protein antigens are not able to extensively crosslink
the antigen receptors on B cells and require T cell help to provide the
signals necessary for growth and differentiation (4).
lymphocytes are also derived from a bone marrow precursor
and they mature in the thymus (5, 6). cells have helper, cytotoxic
and regulatory roles in the immune response. cells recognize
antigen in a different way than do B cells. B cells can ' see' antigen in
solution or bound to the surface of a cell or organism by recognition
of particular epitopes found in the primary sequence or tertiary
structure of the antigen. T cells can only ' see' processed antigen (as
linear sequences of amino acids) bound in the cleft of a class I or
class II major histocompatibility complex (MHC) protein on the
surface of an APC (1). APCs pick up (through specific and nonspecific
means) or synthesize proteins which are processed in some internal
compartment and then become associated with MHC molecules which
II'
are expressed on the cell surface. Once activated by an APC, T
lymphocytes become effector cells and perform the role prescribed
by the circumstances of its activation (2).
B cells get help for antibody responses by acting as APCs to T
cells specific for the same (or linked) antigen (7). However, small or
unactivated B cells do not have the ability to activate a naive T cell
which requires some additional signal or signals found on other types
of APCs (8, 9).
This two (T cell/APC) or three (T cell/APC/B cell) cell
interaction can generate a specific immune response to almost any
protein antigen. The antigen receptors found on T and B
lymphocytes are generated from random rearrangement of variable,
joining, and/or diversity segments found in the gene complexes of
the Ig and T cell receptor (TCR) genes. This random rearangement
has the potential to generate enormous diversity in both T and B cell
receptors allowing recognition of almost any protein sequence which
can be generated (10). However, the immune system must have a
mechanism to inactivate or remove T and B cells which are reactive
to self proteins and peptides in order to avoid generating immune
responses toward self. During their maturation T and B cells reactive
with self antigens are deleted from the repertoire generating a
mature population of cells without self-reactivity.
Cell Maturation in the Thymus
Since this thesis will look at T cell tolerance I will confine 
discussion of the selection process to the T cell arm of the immune
system. T cells mature in the thymus (6, 11). T cell precursors
migrate to the thymus from the bone marrow, where they arise from
maturation of pluripotent stem cells (5, 6). Once in the thymus these
cells begin to proliferate and rearange their TCR genes. TCR alpha
(ex) and beta (13) chains are comprised of variable and joining, or
variable, diversity and joining regions producing a very diverse
population of T cells (10). Successful synthesis of the ex 13
heterodimeric TCR leads to low levels of surface expression of that
TCR with two accessory molecules, Cluster of Differentiation (CD)4
and CD8 (5, 12), which interact with either MHC class II or MHC class
I molecules, respectively (13 , 14).
MHC molecules are a set of polymorphic proteins with a large
number of alleles (15). The molecules are structurally related to the
Ig superfamily of proteins, with a constant membrane proximal
region and a variable region which is very polymorphic between
alleles (16). This variability changes the ability of these MHC
molecules bind antigenic peptides as well as with TCRs. In the mouse
there are three expressed class I molecules K, L, and D; and
potentially two class II molecules, I-A and I-E. Class I MHC
molecules are expressed on virtually all cell types, while class II MHC
molecules are expressed on a very limited variety of cells
predominantly B cells, macrophages and dendritic cells, as well as
some endothelial lineage cells which can be induced to express class
II MHC by interferon y (IFN y) (15). CD4 and CD8 molecules interact
with either class I or class II MHC, probably in some nonpolymorphic
portion of those molecules. Those T cells bearng CD8 interact
primarily with antigen in association with MHC class I and those T
cells bearing CD4 interact with antigen in association with MHC class
II (17, 18). At some time during T cell maturation these immature T
cells lose expression of either CD4 or CD8, as a consequence of a
selection process, and are then committed to interactions with either
Class I or Class II MHC molecules respectively (7).
The T cell receptor also interacts with MHC molecules.
recognizes the antigen (in the form of a peptide) in association with
one of the specific alleles of MHC (19).
Since the initial repertoire comes from a random
rearrangement from hundreds of variable segments TCRs do not
always have affinity for self-MHC with or without antigen. The
thymus must select those TCR with affinity for self-MHC. This
positive selection appears to be mediated by an MHC class I and class
II bearing epithelial cell population in the thymus (20-24).
Self proteins are processed and presented constantly by the
MHC molecules present on all cells (25, 26). Since among the
variations of TCR molecules are receptors reactive with protein
sequences present in self proteins, the thymus has another critical
job and that is to remove those T cells with receptors having self
specificity.
Negative selection of the T cell repertoire appears to be
mediated by a population of bone marrow derived cells (probably
the dendritic cell located at the cortical/medullary junction) (27-30).
There is no evidence as yet which shows how positive or
negative selection is mediated. For positive selection there are two
prevailing theories to explain this finding. First, selection occurs by
an affinity model. cells bearing receptors with some affinity for
self MHC are rescued while T cells bearing receptors with no affinity
for self MHC go on to die via programmed cell death or apoptosis.
This mechanism has no requirement for a particular peptide to be
associated with the MHC molecules, but since MHC molecules are
rarely found empty, peptides may be less important in this stage of
selection. The second model is that there are a unique set of
peptides associated with the thymic epithelium which are
responsible for positively selecting the MHC linked repertoire of the
T cell pool (31).
The mechanism of negative selection is also unknown but one
theory for the mechanism of this selection is that signalling through
the TCR/CD3 complex at this stage of maturation leads to cell death
(32, 33). Thymic dendritic cells present self peptides, and those T
cells which have affinity for these self peptides and the associated
MIC die.
After these selection events occur, the levels of the TCR
increase and these more mature cells move into the medulla of the
thymus, where they are exported into the peripheral circulation.
This selected population of mature T cells bears receptors which
have affinity for self-MHC (with or without peptide) but have been
negatively selected to remove reactivity for self peptides presented
on the self-MHC in the thymus (7).
Peripheral Tolerance
If thymic tolerance were complete, all proteins manufactured
by the organism would be presented by the thymic APCs which
would remove all the potential self reactive T cells. However, some
proteins which are sequestered or developmentally regulated, may
not be expressed in the thymus (34, 35). Some of these proteins, like
myelin basic protein (found in the central nervous system), can then
be immunogenic if the barrier to their recognition is broken and
autoimmunity results. Some proteins, especially cytokines or
hormones, are expressed locally and at concentrations too low for
thymic presentation.
If all proteins are not presented in the thymus, then to avoid
autoimmunity a peripheral tolerance mechanism must be employed
to complete tolerance to self. Since specific immune recognition of
protein antigens requires T cells, whether as effectors or as helpers
and T cells require an APC for antigen recognition, it is necessary to
investigate the role of APCs in the induction of peripheral tolerance.
Antigen Presenting Cells
APCs are a specialized class of cells which all express, to
varying degrees, the class II MHC molecules. The classical antigen
presenting cells are M~ , dendritic cells, and B cells.
M ~ s are bone marrow derived cells, bearing Class II MHC
molecules and having antigen presenting capabilities (36). There are
substantial populations of M~ in the gut and lung, lower numbers in
the lymphoid organs: spleen, lymph nodes and thymus, and even
lower numbers in the blood (as monocytes). These cells are
characterized by two other features which separate them from the
other types of APCs. They are highly phagocytic and are very
adherent. Receptors for complement, Ig Fc regions, denatured
proteins, mannose-fucose, and fibronectin mediate these functions
(31). This makes the M~ a scavenger cell picking up and degrading
antigen/antibody complexes with and without complement attached,
aggregated proteins, carbohydrate antigens as well as bacteria and
other aggregates. M~ can also pick up antigens nonspecific ally by
pinocytosi . However, this nonspecific mechanism is not as efficient
as that mediated by receptors. These phagocytosed materials are
degraded, and some portions of them are processed and presented
via MHC class II to T cells.
Dendritic cells are a loosely grouped class of cell found in many
peripheral sites as well as in lymphoid organs. They are
characterized by having an unusual veiled, interdigitating, or
dendritic shape, high levels of MHC class II molecules, and the ability
to capture antigens and present them to T cells (38). Dendritic cells
are found in very low numbers in the epidermis, heart, liver, lung,
gut, afferent lymph, blood, tonsil, peripheral LN s, spleen and thymus
(38). These cells have been shown to have potent antigen presenting
function (39), but it is not known how they capture antigen. These
cells are not actively phagocytic; they do not express Ig Fc or
complement receptors (with some exceptions) to capture
antigen/antibody complexes; nor do they express the other types of
scavenger receptors found on M~ (38). Dendritic cells do, however
express molecules which are involved in adhesion and potentially
signalling. These include : Cd11a (LFA- l), CD11c, CD54 (ICAM- l),
CD58 (LFA-3), CD29 (131 integrin), and B7/BB-l (38). Very low
numbers of these cells are required to mediated potent T cell
responses both in vivo and in vitro (38). Langerhans cells in the
skin, which have Fc receptors, are thought to convert into dendritic
cells when they migrate (with antigen) into the LNs (38).
B cells are also able to present antigen. As I have described, B
cells must act as antigen presenting cells in order to receive cell
help for antibody responses to most protein antigens. B cells
comprise approximately 40% of the cells in the spleen , and 20% of
cells in the lymph node and peripheral blood (40). cells have been
shown to be very efficient APCs when the antigen is targeted to the B
cell receptor (the surface Ig molecule) (41-43). In addition, B cells
have receptors for lipopolysaccharide (LPS) and complement on their
surface; these aid in antigen pick-up and also activation. These cells
are also capable of processing and presenting antigen to T cell lines
in vitro without being activated themselves (44).
All of these APCs process antigens in much the same way.
Internalized antigens are routed to an endosomal compartment
where they are degraded into peptides and become associated with
class II MHC molecules which are then expressed on the cells surface.
Effective Antigen Presentation
Effective antigen presentation reqUIres the interaction of a 
cell receptor with self MHC plus a specific foreign peptide. This
interaction is not sufficient, however, to activate a resting cell (45).
During T/B collaboration in the antibody response, there are
additional signals required for this interaction to be productive from
both the T cell and B cell perspectives. These additional signals
include adhesion and/or signalling by cell surface molecules and
cytokines, some of which remain to be identified. A two signal
hypothesi was first put forth by Bretscher and Cohn (46) for B cells
and by Lafferty (47) for T cells.
The first signal to the T cell is from the interaction of the TCR
with MHC plus peptide and is probably transmitted through the TCR
associated CD3 complex (45). The second signal may not be unique.
There are a variety of cell surface receptors (on T cells) and ligands
(on APCs) which have adhesive and activating potential. These
include CD2jLFA-3, CD28/BB- , CD4/MHC class II, CD8/ MHC class I
and CD11a: CDI8/1CAM-l and 2 (45). In addition, there are those
cell surface receptors with no known ligand which can activate T
cells with antibody and some additional signal. These include Thy-
Ly- , CD-5, CD- , CD- , CD54, CD44, and CD45 (45). Much emphasis
has been placed on the interaction of CD28 with its ligand B7/ BB-
recently (48, 49), but it is unlikely that it is the only second signal
which can help activate T cells. It is also possible that there are
additional second signals which have not been identified yet.
These two or more signals combined lead to activation of the T
cell. These T cells differentiate and expand as effector cells.
helper T cell can upon antigen recognition on a B cell provide the
cytokine and cell surface mediated help in order to generate an
antibody response.
Ineffective Antigen Presentation
Primed B cells and small B cells have been shown to present
antigen to T cell clones, lines and primed T cells both in vivo and in
vitro (42, 43, 50). However, there is evidence, both in vivo and in
vitro, showing B cells to be poor APCs both in the allogeneic mixed
lymphocyte reaction (MLR) and in primary antigen specific
responses. Metlay and Steinman (39) have shown dendritic cells to
be 50-100 fold better than large anti-Ig activated B cells as APC in
MLR, and small B cells to be inactive. Lechler and Batchelor (51)
showed that injected dendritic cells but not B cells induce rejection of
renal allografts which have been transplanted into secondary hosts.
In an adoptive transfer protocol, Sprent (8) looked at the cell type
inducing primary helper T cell responses in vivo with sheep red
blood cells and found that small thoracic duct B cells had no antigen
presenting capacity. Lassila et al (9) showed that chicken B cells in
chimeric animals were unable to make a thymus dependent antibody
response without MHC compatible macrophages. Webb et al (52) and
Cowing and Chapdelaine (53) showed APC activity by small B cell in
MLR. However, since not all MLR reactivity measures a primary
response (54), small B cells may have been activating mostly
memory T cells in these reports. This evidence indicates that
unmanipulated, small, resting B cells are poor antigen presenting
cells for primary T cell responses, although they can provide the
necessary interactions to get help from an already activated T cell.
What are the consequences of ineffective antigen presentation?
B Cells as Tolerogenic APCs
This thesis proposes that presentation of antigen by a small
resting B cell to a small resting T cell is tolerogenic and results in loss
of T cell activity. This model is supported by evidence from Ryan et
al (55) who showed that in vivo injection of small (accessory cell
depleted) spleen cells from allogeneic donors into normal mice
produced hyporesponsiveness (in MLR) which lasted at least 13 days
post transfer. However, transfer of whole spleen containing M~ and
dendritic cells produced transient hyporesponsiveness followed by
hyperresponsiveness. More recent evidence of B cell involvement in
tolerance induction comes from Hori et al (56), who has shown that
injection of Fl (bml2 x B6) accessory cell-depleted spleen cells into
B6 mice results in prolonged survival of bm12 skin grafts and
diminishes the MLR against bm12 cells. That the predominant MHC
class II bearing cell in both these populations is a small B cell further
supports our hypothesis.
Schwartz and colleagues (57-60) have shown that fixed APCs or
signals which engage the TCR alone deliver to type 1 T helper cell
lines (TH) an abortive signal which results in anergy. This abortive
signal produces a rise in intracellular Ca++ and an increase in the
expressio of IL- receptors, but no secretion of IL- , and the cells
remain unresponsive to complete activation signals for weeks (59).
This model for T cell inactivation by ineffective antigen presentation
is also appropriate for the signal provided by the small B cell to the
naive T cell (61).
Acquired Soluble Protein Tolerance
Peripheral self tolerance is difficult to distinguish from
tolerance acquired during maturation, and many investigators have
used acquired tolerance to foreign antigens as a model for peripheral
self tolerance. Acquired tolerance is a state of specific
unresponsiveness brought on by previous exposure to a normally
antigenic molecule in a form, dose or route which leads to this
unresponsiveness (57).
series of investigators, starting in the early sixties, showed
that injection, intraperitoneally or intravenously, of soluble protein
antigens (particularly when deaggregated or ultra-centrifuged)
produced tolerance to a challenge with a more immunogenic form of
the same antigen (usually complete or incomplete Freunds adjuvant).
These antigens include bovine serum albumin (BSA)(Mitchison(62)),
human gamma globulin (HGG)(Weigle et al (63)), bovine gamma
globulin (BGG)(Dresser (64) and Clayman (65)), and flagellin (Shellam
and Nossal(66) and Parish and Liew (67)). The cumulative evidence
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from this type of tolerance induction is that low doses (less than one
mg/mouse) of soluble (monomeric) antigen in either single or
multiple doses induced tolerance in T cells (68-70). Higher doses of
antigen were needed (greater than one mg/mouse) in order to induce
B cell tolerance (70).
Tolerance in T cells is induced in a short time period. For
human and bovine y globulins 2-4 days were required before
tolerance could be transferred (70, 71). Complete recovery from
tolerance to these soluble protein antigens takes between 4-
months (70, 71). Recovery does not appear to be related to the loss
of circulating antigen, since passive immunization (which should
absorb antigen into immune complexes) during tolerance did not
affect recovery (71). However, by generating immune complexes
which can accumulate in the follicular dendritic cells of the thymus
(37) this may reinforce tolerance by aiding immunologic memory.
Mechanisms of Tolerance
cell tolerance can occur by at least three known mechanisms:
anergy, deletion, and suppression. These three mechanisms are not
mutually exclusive and in some cases have been shown to overlap.
Suppression has been shown to co-exist with nonfunctional cells
(whether by anergy or deletion is unknown) (72). Anergic cells have
II!
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been described which persist after the majority of antigen reactive
cells have been deleted (73).
The easiest form of tolerance to understand is deletion. Once
an antigen responsive population has been deleted it is impossible to
activate that population. Deletion has been vividly demonstrated by
Kappler et al utilizing the affinity of certain families of variable
regions of TCR 13 chains (V 13 ) T cell receptors with the class II MHC
molecule I-E. They showed that in mice which express I-E in the
thymus VJ3 17a+ T cells were lost during maturation. There were
Iii
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immature VJ317a+ cells bearing CD4 and CD8 present in the thymus
but no mature single positive cells present (CD4 or CD8 only) in these
mice (29, 30). Apoptosis has been demonstrated in the thymus of
mice transgenic for a TCR reactive with a peptide of ovalbumin (74).
Upon addition of the specific ovalbumin peptide with which this TCR
reacts, they could detect massive cell death and the ladderlike
appearance of fragmented DNA in the thymus characteristic of
apoptosis. Since the majority of T cells in the thymus never leave
the thymus, this mechanism is thought to be the major mechanism of
thymic tolerance (7).
Anergy is less simple. Anergic or unresponsive cells have been
described in a number of systems of tolerance. Why the immune
system would first turn a particular cell off and then leave in the
circulation is unknown. Three theories cover this finding. First, that
these cells are all in the process of dying and that at any one given
time there are cells, not yet dead, which can be harvested but not
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activated. This mechanism is implied in the anergic cells
demonstrated by Webb et al and Rammensee et al (75, 76).
Rammensee found anergy when they transferred cells bearing a
foreign minor lymphocyte stimulating (Mis) antigen into mice.
However Webb repeated this experiment but first removed the
thymus and found clonal deletion, after a period of cellular
expansion. This implies that if there are no newly emerging cells
from the thymus then the cells are deleted and possibly indicating
that the anergic cells Rammensee found were short lived.
The second theory is that these cells perform some function
which maintains the tolerant state of the individual. These cells are
in fact obstructing, or reinforcing the tolerant state, or tolerizing
other cells (34, 77 -79).
One final theory involves the reactivation of these cells.
Goodnow has a B cell tolerance system derived from mice transgenic
for antibody and antigen (80). In these mice he has recently shown
that tolerance can be broken by repeated stimulation (81). This
would indicate a role for anergic B lymphocytes as antigen reactive
cells held in an unresponsive state until highly stimulated.
Clonal anergy has been demonstrated in systems where there
are an unusually large number of responding T cells (34, 76) or in
mice transgenic for particular T cell receptors (73). Lo and
Rammensee both took advantage of the families of VJ3 TCRs
responsive to MHC class II molecules or the minor stimulating
antigen, Mis. In both of these cases with peripheral expression
1 8
. through transgenic expressIOn of a foreign MHC or transfer of Mis
bearing cells, anergic T cells could be found in the circulation. Teh et
al. have made mice transgenic for a TCR reactive with the male minor
When the trans genes
,,c histocompatibility locus antigen, H- (73).
were bred into male mice (which express H- Y), most of the T cells
bearing the transgenic T cell receptor were anergic. When these
anergic cells were transferred into secondary hosts, whether primed
to H- Y or naive, the cells remained unresponsive (82).
The anergy or unresponsiveness induced has characteristics
similar to the tolerance induced in vitro using cloned helper T cell
lines and fixed APCs (58, 83), irradiated B cells (61), free antigen
(84), plate bound MHC class II molecules (85), or inappropriate APCs
(86). In all these papers, helper T cell clones were inactivated by
exposure to antigen in an inappropriate manner or where there was
an absence of secondary signals (see page 10, effective antigen
presentation).
Suppression is the least clear system of all. Suppression or
infectious tolerance was first described by Gershon and Kondo (87).
They could demonstrate a population of T cells which could be
adoptively transferred into secondary hosts and transfer the
suppression. Suppressor cells fell into disrepute when the putative
marker (I-J) for them was not found at its presumed location (by
genetic mapping to a site in the MHC class II region). Also, efforts to
clone suppressor cells have not been uniformly successful. In some
cases cloned suppressor cells failed to have functional TCR (88).
However, even if there is no umque suppressor lineage, there are
many functions of activated T cells which can, in an antigen specific
manner, effectively stop an immune response. These include
cytotoxic cells, and suppressive cytokine release such as 
IFN y or
IL- IO. There are also systems of tolerance induction which do
contain a population of cells capable of transferring
unresponsiveness which is a hallmark of 
suppression (35, 89-91).
response related to suppression is immune deviation or split
tolerance. Parish and Liew (67) and Silver and Bennacerraf (92)
have demonstrated under some conditions that antibody tolerance
can co-exist with normal responses to delayed type hypersensitivity
(DTH), a cell mediated immune response. Also, Otten et al (93) has
shown split anergy in CD8+ T cells, which no longer secrete IL-2 but
do retain cytotoxic activity. We know that certain types of antigens
and adjuvants (2, 94) influence the type of cells activated and the
types of cytokines that they produce. It has been postulated that B
cell antigen presentation activates the type of helper T cell which
proliferates, secretes IL- , and is able to mediate DTH (96) (the THI
type cell), but does not help antibody production (2, 95, 96).
helper subsets by virtue of the cytokines they secrete are mutually
antagonistic toward one another. THI type cells secrete IFN y, which
inhibits the TH2 type cytokines, and TH2 cells secrete IL- , which
inhibits secretion of THI cytokines (2).
APC in Soluble Protein Tolerance
The APC which mediates acquired tolerance to soluble proteins
has not been defined. Using low doses of deaggregated antigen, the
most likely APCs are the relatively rare antigen specific B cells
which have antigen specific immunoglobulin molecules on their
surface. These B cells could concentrate and process the antigen, but
would not be activated by binding antigen since deaggregated
antigen would not extensively cross-link B cell membrane Ig.
outlined above the interaction of an antigen specific resting T cell
with an antigen specific resting B cell may be ineffective due to a
lack of a costimulatory signal or signals, which are already present or
unnecessary in previously activated cells.
The common thread which ties all of this together is that T cell
tolerance may result from antigens presented by an ineffective APC
which can pick up the antigen preferentially because of the
concentration, location , and state of aggregation. Some of the
features of soluble protein tolerance which favor small B cells as the
APC are shown in Table 1.
The other APCs will not see these antigens because the
macrophage receptor system is set up for aggregated proteins or
antigen/antibody complexes, the antigen is in a location which does
not favor pick up by dendritic cells (dendritic cells comprise less
than 0.01 % of the peripheral circulation (38)), and the concentration
is too low for nonspecific antigen pick up via pinocytosis (41 , 42).
TABLE 1
FACTORS WHICH INFLUENCE THE APC IN TOLERANCE TO
SOLUBLE PROTEIN ANTIGENS
Route LV. predominant MHC class II bearing
cell is the small B cell
Dose less than 1 mg. most efficient receptor system
is the antigen specific B cell
Form de aggregated unactivated, small antigen specific
B cell, not picked up as particles
by M~s
Model for Soluble Protein Tolerance and Small B Cell Antigen
Presentation
To test the hypothesis that small B cells are the APC involved
in soluble protein tolerance in vivo, we needed a way to target an
antigen directly to small , resting B cells. This target must be present
on resting but not activated B cells, must not activate the B cells by
binding, and must not have a high concentration in the circulation in
a soluble form.
Our lab has previously shown that small B cells can process and
present Fab fragments of rabbit anti-mouse anti-IgD (Fab anti-
very efficiently to our rabbit Ig specific helper T cell lines (97). Fab
anti -0 alone does not activate B cells in vitro; they show no increases
in MHC class II expression, size, or DNA content (97). Since we know
that small, resting B cells can process this antigen while remaining in
a resting state (44), we felt that this would be good system for
looking at antigen presentation by small B cells to naive T cells.
The goal of this thesis is to show that an antigen targeted to
small B cells in vivo can induce tolerance. I will also show that
although the antigen specific B cells are affected the primary defect
is in the T cell population. The response to the antigen has not been
shifted toward different Ig isotypes nor toward a strictly cell-
mediated response. In addition, the tolerance induced is not solely
the result of suppression.
CHAPTER n.
MATERIAS AN METHODS
Mice. BALB/c x DBA/2 mice (CD2Fl) and BALB/c mice were
from the National Cancer Institute (Frederick, MD. Mice with severe
combined immune deficiency (CB. 17 SCID mice)(98) and CB. 17 mice
were bred at the University of Massachusetts Medical Center animal
facility and were from stock kindly provided by Donald Mosier
(Medical Biology Institute, LaJolla, CA). Female, age matched mice
were used in each experiment (except as noted), and the mice were
20 weeks old at the start of each experiment.
injected and bled from their lateral tail veins.
The mice were
Anti ens and Antibodies. Rabbit anti-mouse IgD was prepared
in rabbits as previously described (99). The antibody was purified
from rabbit sera by affinity chromatography on IgD columns
removing anti-IgG and anti-IgM crossreactivity on appropriate
columns first. Immunoprecipitation of 0 (IgD) chains but not ~ (IgM)
chains from 1251 -labeled B cells was done to check specificity (97).
Fab fragments were prepared by incubating intact antibody with
papain coupled to agarose (Sigma Chemical, St. Louis, Mo) and then
separated from Fc fragments by passage over Protein A sepharose
columns. Separation of Fab fragments from whole rabbit Ig was
confirmed by polyacrylamide gel electrophoresis. F(ab)'2 fragments
were prepared by pepsIn digestion. Rabbit anti-azophenyl arsonate
(anti-ars) antibody was prepared in rabbits and purified by affinity
chromatography. Nonimmune rabbit immunoglobulin (NRG),
prepared from Cohn fraction II and III, was purchased from Sigma
Chemical Co, and absorbed Fab NRG was prepared by incubating Fab
NRG with whole murine spleen cells for one hour at C. Chicken Ig
was purchased from Calbiochem-Behring (La Jolla, CA). Bovine
serum albumin (BSA) was purchased from United States Biochemical
Corp. (Cleveland, OH). DNP (2,4 dinitrobenzenesulfonic acid sodium
salt) from Eastman Kodak (Rochester, NY) was coupled to BSA
chicken Ig, and F(ab)'2 NRG by the method of Mishell and Shigi (100)
with approximately one DNP per molecule. Rabbit anti-mouse heavy
plus light (H+L) chain or isotype specific horse radish peroxidase-
coupled antibodies were purchased from Southern Biotechnology
Associates (Birmingham, AL). Complete and incomplete Freunds
adjuvant (CFA and IF A) were purchased from Gibco Laboratories
(Grand Island, NY). Killed Bordetella pertussis (R. pertussis) was
purchased from the Biological Laboratories at the State Laboratory
Institute (Jamica Plain MA). Endotoxin levels in antigens were
measured by Pyrotell Limulus amebocyte lysate assay (Associates of
Cape Cod Woods Hole, MA). All antigens used had less than 15 ng
endotoxin/mouse at the maximum injected dose.
Other Rea ents. For cell culture and washing, RPMI 1640
(Gibco Laboratories, Grand Island, NY) with fetal calf serum (FCS)
added (Hyclone Laboratories, Logan, UT) was used.
are listed as used.
Other reagents
Transfer of ulsed small B cells. Small B cells were prepared
from pooled whole normal spleens from CD2Fl mice by centrifugal
elutriation as previously described (42). In one experiment adherent
cells were removed by allowing those cells to adhere to plastic for 2
hours (hrs) at 37 C. The cells were pulsed either overnight or for
one hour at 37 C with Fab fragments of anti-o and injected
intravenously (Lv.) or intraperitoneally (Lp.) at various cell
concentrations into normal CD2Fl mice. After seven days the mIce
were challenged with 100 ~g Fab NRG precipitated in aluminum
potassium sulfate (alum) and bled at weekly intervals for anti-rabbit
Fab antibodies.
Tolerance Induction: Molecules used as tolerogens were
centrifuged at 160 000 x gravity (g) in an airfuge (Beckman
Instruments Palo Alto, CA) for 60 minutes and the top 60% of the
solution was used. Tolerogens were injected in a volume of 0.2 ml in
phosphate buffered saline (PBS) Lv into the lateral tail vein of the
mice. After seven days the animals were challenged Lp. with 100 ~g
of Fab NRG in 0.2 ml precipitated in alum. Most animals also
received 20 ~g chicken Ig precipitated in alum at a separate site Lp.
The animals were bled from the tail veins at weekly intervals and
the serum tested for anti-rabbit Fab antibodies.
ELISA. Antibody titers were measured by a sandwich enzyme
linked immunosorbent assay (ELISA) assay in which serial dilutions
of mouse sera starting at 1 :40 were incubated with antigen (F(ab)'2
NRG, chicken Ig, rabbit anti-mouse Ig, or DNP-BSA) bound to flexible
polyvi y1chlorid plates (Becton Dickinson Labware, Oxnard CA) and
blocked with 1% BSA in PBS. The plates were washed with PBS +
05% Tween 20 (polyoxyethelene-sorbitan monolaurate) (Sigma
Chemical Co.) and incubated with rabbit anti-mouse IgG H+L chain or
anti-isotype antibody coupled to horseradish peroxidase. The
substrate and color developer were 3, 5 , tetramethy I-benzidine
(ICN Biologicals, Lisle, IL) withH202 added. The reactions were
stopped by the addition of 2M H2S04. Plates were read at 405 vs 530
nm on a Dynatech ELISA platereader (Dynatech Laboratories, Inc.
Alexandria, V A) and antibody concentrations determined by
comparing optical density (O. ) with a mouse anti-rabbit Fab
standard or purified mouse anti-ars antibodies of different isotypes
which had been purified by affinity chromatography. Analysis of
antibody titers was made by logistic analysis ("Immunosoft
copyright 1983 Dynatech Laboratories, Inc.) and those dilutions in
the most accurate range of the plate reader were averaged to
provide microgram/milliliter (~g/ml) equivalents.
Ado tive transfer. Balb/c mice were injected Lv. with 100 ~g
Fab anti- On day five, spleen and lymph node cells were harvested.
The spleen cells were depleted of T cells as previously described (97)
by treatment with an anti- cell cocktail (anti-Thy- , anti-CD4, and
anti-CD8) followed by a mouse anti-rat kappa (x:) antibody and then
agarose absorbed guinea pig complement (tolerant B cells). The
lymph node cells were depleted of B cells by panning on rabbit anti-
mouse Ig coated plates by the method of Wysocki and Sato (101)
(tolerant T cells). These cells along with T and B cells collected and
, separated from untreated, control Balb/c mice (normal T and normal
B) were transferred Lv. into SCID mice. Two days later the
reconstituted SCID mice were challenged Lp. with 100 ~g Fab NRG +
20 ~g chicken Ig each precipitated in alum. In the cell titration
adoptive transfer mice were challenged with 100 ~g Fab NRG plus 20
~g chicken Ig precipitated in alum with 2 x 108 B. pertussis added.
All SCID mice were shown to have less than 5 ~g Ig/ml (by ELISA)
prior to transfer. T cells were c:l% sIg+ and B cells were c:l% Thy-
when stained with biotinylated anti-mouse Ig or anti- Thy- l plus
FITC-avidin.
In vitro roliferation. CD2Fl mice were injected with 100 ~g
Fab anti-o. Tolerant and control mice were challenged seven days
later with 100 ~g Fab NRG either precipitated in alum Lp. or
emulsified in CFA subcutaneously (s. ) at the base of the tail. After a
further nine days spleens from the alum primed mice or draining
LNs ("inguinal and aortic) from the CFA mice were collected. Whole
cell suspensions of LN or spleen were plated in RPMI 1640 with 10%
FCS and 100 U/ml penicillin, 100 ~g/ml streptomycin, 2 mM 
glutami , and 5 x 10-5 2-mercaptoethanol. 2,4, or 8 x 105 cells/well
were plated with 50 or 100 ~g/ml F(ab)'2 NRG for 72 , 96, or 120 hrs
at 37 C in 5% C02 with 3H thymidine added for the last six hours of
the culture. Cells were harvested on a Skatron harvester (Skatron
Inc Sterling, Va) and counted on an LKB betaplate scintillation
counter (LKB Instruments Gathersburg, MD). Counts per minute over
background (delta cpm) were calculated by subtracting proliferation
without added antigen from proliferation with antigen.
Neonatal tolerance. Male and female CB. 17 mice were made
tolerant by Lp. injection of 500 ~g Fab NRG emulsified in an equal
volume of IF A in a total volume of 0. 1 ml. within 24 hours of birth.
All mice were bled at seven weeks of age and tested for anti -rabbit
Fab antibodies by ELISA.
Mixin Eight week old male and female CB.17 mice were made
tolerant by Lv. injection of 100 ~g Fab anti-o as described. LNs and
spleens from these mice (five days after anti- injection) and
neonatal tolerant mice described above (at eight weeks of age) and
normal unprimed mice were separated into T and B cells as
described above. T and B cells from these mice were injected Lv. into
eight week old SCID mice in various combinations, mixing normal
with tblerant T cells plus normal B cells. After two days the mice
were challenged with 100 ~g Fab NRG and 20 ~g CGG. The SCID mice
were bled weekly and antibody titers measured by ELISA.
CHAPTER III.
RESULTS AN DISCUSSION
Transfer of Small Pulsed B cells
The first attempt to test whether cells induce tolerance was
to inject small and or large B cells, which had been pulsed with Fab
anti-O into mice and measure the subsequent response of these mice
to a challenge with rabbit Fab precipitated in alum.
did not succeed.
This approach
The initial experiment involved normal spleen cells, depleted of
cells with antibody and complement, depleted of M~ by plastic
adherence, and elutriated for size. The cells were incubated
overnight with Fab fragments of anti- Normal mice were injected
with these pulsed cells either i.v. or i.p. at either one or ten million
cells per animal. The control groups were mice injected with 3 x 106
large pulsed cells or untreated mice. All mice were challenged after
seven days with 100 ~g Fab NRG precipitated in alum.
are summarized in Table 2.
The results
The second experiment involved different conditions for the
preparation of the small cells. cells were not removed and the cells
were elutriated without any protein in the medium. The cells were
incubated for one hour at 37 C with Fab anti-o. The results are
summarized in Table 3.
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TABLE 2
TRANSFER OF PULSED CELLS #1
cells Route esults
10 x 106 LV. primed
1 x 106 LV. primed
10 x 106 Lp. unaffected
1 x 106 Lp. unaffected
3 x 106 large cells LV. primed
Table 2. Injection Lv. or Lp. of 1 or 10 x 106 small B cells or 3 x 106
large cells pulsed with Fab anti- overnight. Mice were challenged
after seven days with 100 ~g Fab NRG precipitated in alum Lp.
Primed cells showed responses at day of challenge and/or higher
overall response. Unaffected mice were the same as uninjected
control mice.
TABLE 3
TRANSFER OF PULSED CELLS #2
x 106 Lp. unaffected
x 105 Lp. unaffected
x 1() Lp. unaffected
x 106 large cells Lp. primed
- '"
TABLE 3. Injection of graded doses of small or large spleen cells
pulsed with Fab anti-o into mice. All mice were challenged after
seven days with 100 ~g Fab NRG precipitated in alum.
The last transfer experiment involved injection of pulsed cells
twice a week for two or four weeks. In this experiment all the mice
were primed (results not shown). This was probably due in part to
the difficulty I had in actually injecting the mice intravenously.
Conclusions. Except for the mice receiving the highest doses of
cells there was no effect of these small pulsed cells on the resultant
immune response. The large cells did prime the mice, however.
This approach may not have induced tolerance for a number of
reasons. It may have been that in this model system the transferred
cells never reached the appropriate location for tolerance induction
or there was no ' space' in these normal mice for the injected cells.
However Rammensee (76) was able to transfer Mis disparate cells
into normal mice and induce tolerance. Additionally, Victoria
Yuschenkoff has been able, in our lab, to induce tolerance by transfer
of whole spleen or LNs into normal mice, using mice transgenic for
human Ig ~ chains as donors for the transferred cells (102).
An alternate explanation is that the antigen did not remain
presented for a long enough time to induce tolerance. Gosselin et al.
(44) showed , with in vitro presentation of rabbit anti-mouse Ig by
small B cells to T cell lines, a loss of antigen presentation (as
measured by cytokine release) starting 12 hours after pulsing with
antigen. This may indicate a gradual loss of antigen or antigen
presenting capacity with time.
Since I was unable to induce tolerance by transfer of small B
cells, I decided to abandon this protocol. I decided to try injection of
soluble Fab anti-o. Injection of soluble ultracentrifuged Ig molecules
has been used very effectively in the past to generate antibody
tolerance (63-65). Our laboratory had available rabbit anti- , which
is specific for the majority of small B cells in the mouse. Also since
there is only a low level of circulating IgD in the mouse there would
be little immune complex (IgD anti-IgD complexes) formation. Since
the Fab fragments do not activate small B cells (97), I can look at
antigen presentation in vivo by small B cells.
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Injection of Ultracentrifuged Fab Anti-
For this group of experiments I developed a technique from the
protocols used in classical methods of tolerance induction for soluble
protein antigens. Tolerance to ultracentrifuged Ig molecules has
been induced using a single injection of as low as 100 ~g (68). The
tolerance requires 2-5 days to be induced (71 , 103). Challenge was
with heat aggregated (63), CFA emulsified (65, 71) or alum
precipitated (62) antigen and was given 6 days to two weeks later in
most cases. Figure 1 shows the general protocol followed in all the
experiments to follow. All exceptions will be noted in each section.
Anti- ected into mice induces tolerance to rabbit lobulin.
Our model system involves injection of 100 ~g of ultracentrifuged
Fab rabbit anti- intravenously into normal CD2Fl mice followed by
challenge with Fab NRG precipitated in alum seven days later. These
animals become profoundly tolerant to rabbit Fab as measured by
antibody production in an ELISA assay. Figure 2 and Table 4 show
the results of one such experiment. These mice were followed
weekly until day 64 post-challenge, when three of the six tolerant
mice stiJl made less than 5% of the mean control anti-rabbit Fab
response. The difference between the control and tolerant mice is
generally greatest at day 21 or 28 post challenge. At this point
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Figure 2. Serum anti-rabbit Fab antibody levels in ~g/ml from mice
injected Lv. with 100 ~g ultracentrifuged Fab rabbit anti-o or control
untreated mice challenged with 100 ~g Fab NRG precipitated in alum.
Antibody levels were measured by ELISA at the indicated days post
challenge.
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TABLE 4
TREATMENT WITH DIFFERENT RABBIT Igs
PRE DA Y14 DAY 21 DAY 28 DAY 35 DAY 42 DAY 64
12. 20. 32.
2.4
1.8 126
1.0 2.4
FAB
ANTI- 1.46 41.6212. 44.
209 355 404
52. 125 106
100 146 160
257 358 307
0.4 188 191 216
FAB 354 498 513
ANTI- ARS 193 279 284
109 148 154
130 484 420
256 260
286 295
899 1023
243 292
1418 1697
F2 ANTI - 598 665
473 582
17. 109 319 441
1.7
F AB NRG 154 196
145 212
120 1192 1244 974 834
200 341 331 318 754
482 1447 1221 1606 1698
CONf 267 993 932 966 1095
190 579 521 644 523
TABLE 4. Shown are individual anti-rabbit Fab responses in ~g/ml
of the mice shown in Figure 2 and 6. Groups represented are from
the top: Mice treated with 100 ~g Fab anti-o, Fab rabbit anti-ars
F(ab)'2 anti- o, Fab NRG, or control untreated mice. All mice were
challenged seven days after treatment with 100 ~g Fab NRG
precipitated in alum. Mice were bled weekly at the times shown at
the top of the table and anti-rabbit Fab was measured by ELISA.
Shown in bold are the averages and standard deviations for each
group, which are plotted in Figures 2 and 6.
the control mIce approach their peak response and the tolerant mIce
remain unresponsive.
Summarizing all of the data to date, 35 of 50 mice made less
that 1 % of the control response. Of the remaining mice only 5 made
greater than 5% of the mean control response and only two mice
made responses ::10% (15 and 20%) as shown in Figure 3. Other mice,
which were not tested at day 21 post-challenge, are shown in Figure
4 as percentage of the mean control response at day 14.
do not appear as tolerant as the mice shown in Figure 3.
These mice
However
the control responses have not reached their peak at this time and do
not reflect the full anti-rabbit Fab response and so the tolerance
induced is underestimated. The average response of these 13 anti-
treated mice is 3.5 ~g/ml with only one mouse with a response
greater than 10 ~g/ml.
Anti en s ecificit and B cell function. Injection of mice with
an anti-Ig may result in a global defect in B cell function. Down-
regulation of membrane IgD via anti -0 has been implicated in
tolerance induction in B cells previously (104). One way to look for a
global defect in the B cell population is by an antibody response to an
irrelevant antigen, which will show whether the tolerance induced is
antigen specific. As shown in Figure 5 , these animals all made
normal''; responses to challenge with chicken Ig, also precipitated in
alum, given Lp. at a different site. In all experiments to date the
control and anti- treated mice have equivalent responses, except for
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FIGURE 4. Individual anti-rabbit Fab responses from anti- treated
mice as a percentage of the mean control response at day 14 post
challenge.
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Figure 5. Serum anti-chicken Ig antibody levels in ~g/ml from the
same mice as shown in Figure 2. Mice were challenged at the same
time as challenge with NRG with 20 ~g chicken Ig precipitated in
alum at a separate site. Antibody levels were measured by ELISA at
the indicated days post challenge.
three mice which failed to respond to chicken Ig. The most probable
explanation for these three failures is loss of the challenge antigen
through leakage or missed injection. This indicates that the tolerance
is antigen specific and that B cell function has not been generally
affected by anti-
cells must be tar eted for tolerance to occur. To show that
the tolerance was due to targeting antigen to B cells rather than
other types of APCs, we used a rabbit Ig molecule which was not
targeted to B cells. For this purpose we used either Fab NRG or Fab
rabbit anti-arsonate (anti-ars), a chemical compound not found on
murine cells. Each of these antigens was ultracentrifuged and
injected Lv., and the results are shown in Figure 6 and Table 4.
Although both of these molecules, when injected at this dose (100
~g), reduce the anti-rabbit Fab response neither was as effective as
Fab anti- Whole nonspecific IgG molecules have been used in the
past to induce low zone tolerance (63, 64), but, the half-life of whole
rabbit IgG in the mouse is 5-6 days whereas the Fab fragments have
a half-life of approximately 4 hours (105, 106). The Fab NRG may
not be in the circulation long enough to efficiently induce tolerance in
all cases.
In this and most other experiments with injection of Fab NRG,
some diminished response was found (in all experiments 11 of 23
mice were .:10% of controls at day 21 post challenge while 5 were )-
50% of the controls) as shown in Figure 7 and Table 5. The
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Figure 6. Mean serum anti-rabbit Fab antibody levels in ~g/ml
from five groups of mice treated with different forms and
specificities of Fab rabbit Ig. On the left is the mean response of the
6 mice shown in Figure 1. Next are the average responses from 
mice injected i.v. with 100 ~g F(ab)'2 anti- o; 6 mice injected with 100
~g Fab rabbit anti-ars; 3 mice injected with 100 ~g Fab NRG; and 3
control untreated mice. All mice were challenged as above and
antibody levels measured by ELISA. Bars represent one standard
deviation.
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FIGURE 7. Individual anti-rabbit Fab responses from mice treated
with 100 ~g Fab NRG, as a percentage of the mean control response at
day 21 post challenge.
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TABLE 5
PERCENTAGE OF MEAN CONTROL RESPONSE
FAB NRG TREATED MICENRG % D21
#4-22 13.
#4-23 140.
#4-24 46.
#4-25 257.
#4-26 56.
#4-27 88.
#14- 10.43
#14- 32.
#14- 4.43
# 17 - 23.
#17- 60.
#18- 16.
#18- 1.29
#18-
#18-
#18- 1.13
#18- 13.
#31-
#31-
#31-
#31-
#31- 1.31
#31- 0.44
TABLE S. Values shown are from mice treated with 100 ~g
ultracentrfuged Fab NRG i. v. followed by challenge with Fab NRGprecipitated in alum. The mean uninjected control response from
each individual experiment (shown are five independent
experiments) was calculated and the percentage of the mean control
response w.as calculated for the individual mice shown.
nonresponsiveness was not as profound as the tolerance induced 
Fab anti-o, and the results are not evenly distributed. There is a
greater degree of tolerance induced in the later experiments. Since
injection of small amounts of endotoxin can abrogate tolerance (107),
it is possible that I had higher amounts of endotoxin in the earlier
experiments. I did not begin to measure the levels of endotoxin until
after the first set of experiments were done. I also became much
more adept at Lv. injections with time. Since s.c. injection of antigen
is likely to be picked up by a dendritic cell (38), better injection
would avoid having competition between effective and ineffective
APCs. Neither of these variables (endotoxin levels and injection
success) appear to be as important for the anti- , which may indicate
that the anti-o is a much more effective tolerogen. There is a
significant difference between the mice treated with Fab anti -0 and
Fab NRG. The combined mean of the percent of control response for
the 50 Fab anti- treated mice is 1.74% (standard deviation 3.78)
while that for the 23 Fab NRG treated mice is 33.8% (standard
deviation 59.9).
Dose res onse to NRG. The partial tolerance induced by Lv.
injection of Fab NRG could have been due to anti-mouse activity
found in the rabbit Ig preparation used, since the responses of mice
treated with Fab rabbit anti-ars are closer to the control responses.
With higher concentrations of NRG, lower affinity NRG binding B cells
can be recruited to induce tolerance. However, anti -0 can induce
tolerance at doses as low as 1 ~g (data not shown and see Figure 8
and Table 6A), and the difference between anti- (targeted to all B
cells) and NRG (targeted to rabbit Ig specific B cells) should be
accentuated by lower doses of tolerogen.
To investigate the differences in responsiveness of mouse
spleen cell-absorbed Fab NRG (FAB abs NRG) versus Fab anti-o, a
dose response experiment was done. As shown in Figure 8 and
Tables 6A and B , mice treated with lower doses of Fab abs NRG are
less tolerant than mice treated with equivalent doses of Fab anti -
This difference is the most striking at the lowest dose, 0.5 ~g/mouse.
The mean of the 7 mice treated with 0.5 ~g of Fab anti-O was 18.
~g/ml which is 13.4% of the mean control response. However, the
mean of the 7 mice treated with 0.5 ~g of Fab abs NRG was 205
~g/ml which is 148% of the mean control response. The mice treated
with 5 ~g of Fab abs NRG also made 2.5 times greater mean response
(46.9 ~g/ml) than mice treated with a 10 fold lower dose of Fab anti-
These data indicate that although Fab NRG and Fab abs NRG can
induce tolerance at higher doses ( 50 ~g/mouse), antigens not
targeted to B cells are ineffective at tolerance induction at lower
doses (0.5 ~g/mouse).
Divalent F
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anti- does not induce tolerance. Since
activated B cells have been shown to initiate some T cell responses in
vitro (39), activated B cells may no longer be tolerogenic as APCs.
DOSE RESPONSE FAB ANTI-
VS. FAB ABS NRG
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Figure Mean serum anti-rabbit Fab levels in ~g/ml from mice
treated with 50, 5, or 0.5 ~g/mouse of Fab anti-o or Fab abs NRG. All
mice were challenged as in Figure 2. There are 7 mice in each group.
Bars represent one standard deviation.
TABLE 6A
DOSE RESPONSE
TREATMENT WITH FAB ABS NRG
PRE DAY DAY DAY
#31 136
#32 117 164
#33 112 182#34 169 220
#35 193 329#36 217 237#37 106 169
AVG NRG/0. 30. 143. 205.
13. 49. 64.
#41 9.4 115#42
#43
#44 118
#45
#46 1.5#47
A VG NRG/5 10. 28. 46.
14. 32. 48.
#51 0.3 1.2#52
#53
#54 0.4 0.4
#55
#56 0.4#57
AVG NRG/50 1.99
1.31
CONTROLS
#61
#62 162 211
#63 129#64 110 134#65 103#66 3.5 144 280
#72
A VG/CONT 23. 92. 138.
14. 51.48 82.
TABLE 
DOSE RESPONSE
TREATMENT WITH FAB ANTI-
PRE DAY DAY DAY
# 1 1.4
# 2
# 3
1.7
# 6
A VG S/0. 18.
1.08 12.
# 11
#12
# 13
#14 1.5
#15
#16 0.4
#17 1.2
AVG 5/5 1.66
1.96
#21
#22
#23
#24 1.3
#25 0.4 0.4 1.9
#26
#27 1.7
AVG 5/50 1.65
TABLE 6A and B. Shown are individual serum anti-rabbit Fab
responses in ~g/ml from mice shown in Figure 8. Groups include in
A. mice treated with 50, 5, or 0.5 ~g/mouse Lv. Fab abs NRG and
control untreated mice. In B mice treated with 50, 5, or 0.5
~g/mouse Lv. Fab anti-o. Shown in bold are the averages and
standard
.,.
deviation which are plotted in Figure 
Finkelman et al. have shown that Lv. injection of whole goat anti-
mouse 0 induces polyclonal B cell activation followed by the
appearance of large numbers of surface IgG positive cells and T cell
dependent IgG secretion (108). In addition, Golub and Weigle
showed that injection of LPS around the time of the tolerogen (HGG)
blocked the induction of tolerance (107). LPS can affect M~ as well
as B cells (94) and does not necessarily indicate only activation of B
cells. We tested the effects of B cell activation in our system by
injecting 100 ~g of ultracentrifuged F(ab)'2 fragments of rabbit anti-
into mice followed by challenge as above. Unlike monovalent Fab
fragments, this divalent antigen can crosslink the surface IgD
molecules and could activate B cells in vivo. As shown in Figure 6
and Table 4, the F(ab)'2 anti-o did not induce tolerance. We were not
able in this system to rule out effects caused by aggregation of the
small amount of serum IgD (109) by F(ab)'2 anti- o, but the simplest
interpretation of these results is that the B cells must remain in a
resting state to induce tolerance.
Time of challen Tolerance generated in this system is not
permanent. Over the times tested most mice made an antibody
response to the alum depot of rabbit Fab. Since the original
tolerogen is present for such a short time and mice are not
challenged " 'for an additional six days, it is possible that newly
emerging immune cells can reconstitute the anti-rabbit Fab response.
Alternatively, a very small number of peripheral pre-helper T cells
11'
that escape tolerance induction during the anti- treatment may
expand over the weeks following challenge.
To answer this question, I set up an experiment challenging
at different times post treatment. Shown in Figure 9 and Table
7 are mice treated with 100 ~g Fab anti-O and then challenged at two
or seven days post treatment. There is no striking difference in the
anti-rabbit Fab produced by these two sets of mice. The 'day two
set were lower at all time points through day 56. All the ' day seven
mice were making some antibody by this time. The 'day two' mice
were later and at day 63 three of four remaining mice were making
antibody. The data above indicates that tolerance has been induced
within two days after treatment shown earlier for other Ig
tolerogens (71). Although there is a lower overall response in the
day two' mice , the loss of tolerance is still occurs since three of four
mice in the 'day two ' group made antibody by day 64 post challenge.
This may also indicate the the alum depot does not feed antigen into
the thymus to continue tolerance induction in maturing T cells, as has
been shown by Gahring and Weigle (69).
Conclusions. The data presented above show I can induce
tolerance to rabbit Fab by Lv. injection of ultracentrifuged Fab
fragments of rabbit Ig specific for IgD molecules found on the surface
of the majority of small, resting B cells. Tolerance to soluble protein
antigens is usually described as a loss of reactivity to a normally
, I "
CHALLENGE AT DIFFERENT TIMES POST TREATMENT
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FIGURE 9. Mean serum anti-rabbit Fab response from mice treated
with anti-o and challenge on day two or day seven with 100 ~g Fab
NRG precipitated in alum. Mice were bled on the days post challenge
indicated and anti-rabbit Fab levels measured by ELISA. Bars
represent one standard deviation. Mean control responses for this
experiment are shown in Table 7.
TABLE 7
CHALLENGE AT DIFFERENT TIMES POST TREATMENT
DAY 28 DAY 35 DAY 49 DAY 56 DAY 63
1.1
# 3 1.1
1.1
2 DAYS 10.
12.
# 11 1.8
#12 1.9
# 13
#14
# 15 1.4
# 16
7 DAYS 1.50 10. 17.
1.89 11.76 14.
#41 108 190 300
#42 338 403 714 632
#43 0.4
#44 210 275 404 288
CONTROL 157 197 327 305
148 178 306 258
TABLE 7 Shown are individual serum anti-rabbit Fab responses in
Ilg/ml from mice shown in Figure 9. Groups include: Mice challenged
with 100 ~g Fab NRG two or seven days post anti-o treatment or
control untreated mice. Shown in bold are the averages and
standard deviations for each group.
- not done.
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immunogenic protein induced by administration of that protein by
an alternate route, dose or form of administration (57).
One consequence of these methods of administration is that the
antigen may be processed by an alternate or inappropriate APC.
APCs, like M~, gather antigen by pinocytosis and via receptors for Fc
and complement on their cell surfaces. Dendritic cells gather antigen
by an unknown mechanism, but they are present in their highest
numbers in tissue and not blood (38). In the case of low doses of
soluble protein antigens, the small antigen specific B cells may be the
only cells in the right location with the ability to pick up enough
antigen to affect the T cell response. Although these cells are present
at low frequency (between one in 104 or 105 for protein antigens)
(110), they can pick up and present very low concentrations of
antigen in vitro through antigen specific receptors (41-43). If no
other APC can gather enough antigen, these few small B cells could
present it over time (with a persistent or endogenous antigen) to the
antigen specific T cells. In our model the concentration of anti-
antigen is 100 ~g/mouse but can be as low as 1 ~g/mouse (data not
shown and Figure 8 and Table 6B). The anti-o is immediately diluted
into the blood volume of the mouse, which is approximately 2.5 ml
for a final concentration of 4-40 ~g/ml of anti-o. Tony et al. (42)
have shown, using in vitro antigen presentation by whole spleen cells
or small B'-'cells, that doses of less than 100 ~g/ml of F(ab)'2 NRG are
ineffective at inducing T cell proliferation. However, as little as 0.
~g/ml of F(ab)'2 anti- o, presented by small B cells, could maximally
stimulate the same T cell hybridomas. Without too much
extrapolation of in vitro data to in vivo results it is possible to
conclude that the concentration of the Fab anti-o injected is too low
to be effectively picked up by nonspecific means.
As shown in the dose response data, in Figure 8 and Tables 6A
and B, the lowest dose of Fab abs NRG was completely ineffective at
inducing tolerance. At higher doses (50 and 100 ~g/mouse) Fab NRG
and Fab abs NRG may be able to find enough rabbit Fab specific B
cells within the short lifespan of Fab fragments (105, 106) and
induce tolerance.
F(ab)' 2 anti-o does not induce tolerance. Activated B cells have
been shown in vitro to be better APCs than small B cells by Metlay
and Steinman (39). One explanation for a different functional state
with activation are the cell surface molecules which are expressed
after activation. One such molecule B7/BB-l has recently been
described as the ligand for the T cell activation antigen CD28 by
Linsley et al (49) and Koulova et al (48). Small resting human B cells
do not express the B7/BB- l molecule, but it can be induced upon
activation (48). If this is the costimulatory signal which
differentiates a tolerogenic signal from an activating signal, then our
evidence for prior activation of B cells would fit in with this finding.
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Mechanisms of Tolerance
Tolerance in the T cell compartment has been shown to occur
by at least three different mechanisms (57). Clonal deletion and
anergy have both been shown to account for tolerance in the thymus
(111, 112) and in the periphery (76). In addition, suppression has
been described in peripheral tolerance to BSA (89) and to high ,doses
of fowl gamma globulin (90).
cell tolerance is usually associated with high antigen doses
(greater than one mg/mouse), which results in both T and B cell
tolerance (62, 64, 80, 113). With the dose of antigen I used I
expected to find tolerance in the T cell compartment only.
is com romise anti- treated mice. To
investigate the T cell compartment in anti- treated mice we used a
hapten carier model. DNP is a hapten which requires carrier specific
help in order to elicit an antibody response. We challenged mice
treated with Fab anti-o and control untreated mice with F(ab)'2 N R G
modified with DNP. As shown in Figure 10 and Table 8, these mice
make less than 15% of the control anti-DNP response at day 21 post
challenge. Mice treated with soluble Fab NRG (data not shown) make
an intermediate anti-DNP response which is commensurate with
;";
their anti-rabbit Fab response. Anti-rabbit Fab responses for anti-
treated and control mice are shown in Figure 11 and Table This
, "
ANTI-DNP RESPONSE
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DAY 7
1000 DAY 14
DAY 21
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FAB ANTI- 0
TREATMENT
Figure 10. Top: mean anti-DNP levels in units/ml using as a
standard antiserum a control (day 28 post challenge with DNP-BSA in
alum) serum arbitrarily assigned 1000 units/ml. Shown are mice
injected i. v. as in Figure 1 with Fab anti -0 or control untreated mice
challenged after 7 days with DNP modified F(ab)'2 NRG precipitated
in alum. Mice were bled weekly post challenge and antibody levels
measured by ELISA. Bars represent one standard deviation. Fab
anti-o group contains 6 mice and the control group contains 3 mice.
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ANTI-RABBIT FAB FROM DNP/F2(NRG) MICE
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Figure 11. Mean anti-rabbit Fab responses in ~g/ml for the mIce
shown in Figure 10.
TABLE 8
ANTI-DNP RESPONSE TO DNP-F2(NRG)
PRE DAY DAY DAY
# 1 171 255
193 274
# 3 7.4 170
310 590
150 187
# 6 137
ANT.- 11.42 17. 17. 167. 268.
81.04 165.
#41 6.4 220 1727 1220
#42 525 618
#43 1508 1416
CONT 125. 1253. 1084.
1.57 1.11 82. 640. 415.
ANTI-RABBIT FAB RESPONSE TO DNP-F2(NRG)
PRE DAY DAY DAY
# 1 1.1 to.
0.4 1.6
1.2 4.4
22.
# 5 17.
ANTI- 11.4
#41 .03 0.1 3.5 116. 621.0#42 .1 0.1 3.5 77.0 248.#43 .1 0.1 2.1 120.0 514.CONT 0 . 1 0 . 1 3 . 0 1 0 4 . 0 461.SD 0.04 0.0 0.8 23.8 192.
TABLE 8. Shown are individual anti-DNP responses in units/ml for
the mice shown in Figure 10. Groups represented are : mice made
tolerant with anti-o or untreated control mice challenged with 100 ~g
DNP coupled to F(ab)'2 NRG precipitated in alum.
On the bottom are shown are individual anti-rabbit Fab responses in
mg/ml from mice shown in Figure 10 and in the top panel.
Shown in bold are the averages and standard deviations which are
plotted in Figure 10 and 11 
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data is consistent with a loss of the rabbit Fab specific helper T cell
function.
To look separately at T and B cell function in these anti-
treated mice, T or B cells from anti-O treated BALB/c mice were
transferred, before challenge, with normal B or T cells into SCID mice.
The SCID recipient mice were challenged and bled weekly, and the
data from this adoptive primary antibody response is presented in
Figure 12 and Table 9. SCID mice which received tolerant T plus
tolerant B cells, as expected made less than one ~g/ml of anti-rabbit
Fab. Tolerant T plus normal B gave slightly higher anti-rabbit Fab
titers which were 2% of the control response at day 21. Tolerant B
plus normal T gave low anti-rabbit Fab responses which reached 34%
of control responses by day 35. These data indicate that there is a
loss of rabbit Fab specific helper T cell activity in the anti - treated
mice.
The responses of individual mice in the adoptive transfer
model are variable. Standard deviations are probably not the best
representation of the spread of the data among these mice. The two
groups of mice, in this transfer, with significant antibody responses
are the normal T plus tolerant B and normal T plus normal B groups.
For these sets of mice I have shown the individual data points for
day 35 post-challenge directly on the figure in symbols. There is a
greater d&gree of spread among the normal T plus normal B group
with the range of antibody responses from 147 ~g/ml to 1488 ~g/ml.
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ADOPTIVE TRANSFER
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Figure 12. Mean anti-rabbit Fab response in ~g/ml from SCID mice
reconstituted with T and/or B cells from normal, untreated BALB/c
mice or BALB/c mice injected with 100 ~g Fab anti-o as in Figure 2.
Each group shown contains 5 SCID mice which received 80 x 106
pooled spleen B cells and 20 x 106 pooled lymph node T cells from
either tolerant or normal mice. Mice were bled weekly and anti-
rabbit Fab levels measured by ELISA. The symbols representindividual mice at d35 post challenge for the last two groups (Norm T
+ Tol B and Norm T + Norm B). Also included in this experiment but
not shown wgre 3 mice which received 20 xl06 normal T cells alone
or 80 x 106 normal B cells alone. Neither of thes groups made an
anti -rabbit Fab response.
TABLE 9
ADOPTIVE TRANSFER
PRE DAY DAY DAY DAY
# 11 1.4 1.7#12
#13 1.9
# 14 1.3 1. 7#15 1.4 1.3 1.1TOL T+ TOL B 1.20
1.97
#21 131 720 819#22 232 952 852#23 1.6 7.4 147#24 606 1779 1488#25 9.4 159 162NORM T + B 209. 738. 693.
236. 688. 559.
#31
#32 1.9
#33 7.4
#34 0.4 1.9T ONLY 1.97 13. 31.85
16. 43.
#41
#42 0.4#43 0.5#44 0.4B ONLY
#51 0.4 0.4#52 1.1
#53 1.5
TOL T/NOR B 1.44 27. 41.48
1.10 30. 36.
#61 160#62 229 287#64 134 233
106 234
# 6 204 264TOL B/NOR T 25. 150. 235.
10. 64. 47.
I '
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TABLE 9. Individual serum anti-rabbit Fab response in ~g/ml from
SCID mice reconstituted with T and/or B cells from normal and anti-
tolerant Balb/c mice as shown in Figure 12. Also shown are mice
which received 20 x 106 normal T cells only or 80 x 106 normal B
cells only. Mice were bled weekly at the times indicated post
challenge and anti -rabbit Fab levels measured by ELISA. Shown in
bold are the averages and standard deviations plotted in Figure 12.
Even though the responses of the normal T plus tolerant B
group fall within the range of the normal T plus normal B group,
there is an apparent decrease in the responses generated using 
cells from tolerant mice with normal T cells, indicating that there
may also be some effect in the B cell compartment. B cells from
tolerant mice plus normal T cells transferred into SCID mice made
approximately one-third of the mean response of mice which
received normal B plus normal T cells. This response was delayed
and did not reach the control response by the termination of the
experiment (day 35). This delayed response may be due to recovery
of B cell function, or the clonal expansion of a smaller number of
responsive B cells.
As a control for reconstitution these mice were also challenged
with chicken Ig and then tested for anti-chicken Ig antibodies at day
seven and day fourteen post challenge. All four groups shown made
similar levels of anti-chicken Ig, shown in Figure 13 and Table 10.
This indicates again that there is no effect of Fab anti-o on the
chicken Ig specific B cell population. SCID mice which received
normal T cells only or normal B cells only followed by challenge as
above did not make anti-rabbit Fab or anti-chicken Ig antibodies
indicating that the mice did not have sufficient T or B cells of their
own to mount an immune response and that the level of T and B cell
contamination in the transferred cell preparations was not a factor in
the responses.
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ADOPTIVE TRANSFER
ANTI-CHICKEN Ig RESPONSES
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FIGURE 13. Individual serum anti-chicken Ig responses in ~g/ml
from the mice shown in Figure 12.
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TABLE
ADOPTIVE TRANSFER- CHICKEN Ig RESPONSE
DAY DAY
TOl T + B
# 1 1 328
# 12 194
# 13 4.4 236
# 14 323
# 15 349
NORM T + B
#21 387
#22 114
#23 425
#24 417
#25 314
T ONLY
#31 004
#32 004
#33
#34
B ONLY
#41 0.4
#42
#43 1 .
#44
TOlT/NOR B
#51 641
#52 346
#53 767
# 2 282
# 4 474
TOlB/NOR T
#61 1 1 330
#62 9.4 452
#64
".J # 5 417
# 6 390
TABLE 10. Individual serum anti chicken Ig responses in ~g/ml
from the mice shown in Figure 12 and Figure 13.
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For the rabbit Fab specific B cells the interaction with Fab anti-
o would be a cross-linking interaction, since both Ig molecules (rabbit
and mouse) recognize each other, and both the IgM and IgD
molecules may be involved with the same Fab fragment. Therefore,
the antigen specific B cells could get a signal through their antigen
receptors in the absence of T cell help. Goodnow et al (80) have
shown using antibody transgenic mice that transfer of mature
antigen specific B cells into antigen bearing, T cell tolerant mice
results in B cell anergy. Also, B cell tolerance may require the
involvement of sIgM which can occur only in the rabbit Fab specific
B cell population. This rabbit Fab B cell defect accounts for only a
small part of the very profound loss of the anti-rabbit Fab response
in mice treated with anti-
vitro ferative res onses o anti- versus control mIce.
Treatment of mice with Fab anti- results in an inability of these
mice to generate an antibody response to rabbit Fab. This lack of an
antibody response is only partly due to lowered rabbit Fab specific B
cells function. I have shown in the previous section that there is a
lack of Fab specific T cell help in Fab anti-o treated mice. Antigen
presentation by B cells has been proposed to alter the type of T cell
that is activated (95, 96, 114). We may have skewed the response of
the T cells toward a completely cellular response. There is evidence
that some tolerance protocols spare DTH like responses and ablate
antibody production (92, 115). Whiteley et al. found, in tolerant
animals, a proliferating population of T cells which was unable to
help antibody production (116). It is possible that the tolerance
induced was merely the change from activation of T cells able to help
antibody production to a proliferating population of non-helper T
cells. These could be cells which mediated DTH like responses or a
suppressor population.
To look at the T cell response in anti-o tolerant mice, I set up in
vitro proliferation experiments. Although none of these experiments
is conclusive, the cumulative data show occasional, but much reduced
responses of anti- tolerant mice to rabbit Fab. I had a great deal of
difficulty in getting normal alum or CF primed mice to make
consistent responses to rabbit Fab in vitro. With most of the
conditions I used, which gave responses , there was a very high
background which was between 40-60% of the total response.
as media RPMI with FCS or normal mouse serum as well as a
I used
hybridoma media HL-l (Ventrex Laboratories, Portland ME) with 
added serum. I varied the cell number from 104_3x 1 06 cells/well
and I used a variety of incubation times from three to six days.
also tried to reduce the background responses by isolating T cells
from the spleen or lymph nodes and plating them with mitomycin c
treated unprimed spleen cells as APCs. The most consistent results
were obtained with RPMI with 10% FCS added using whole spleen or
lymph node hnd incubating for 72-96 hours.
Shown in Figures 14 and 15 and Table 11 are data from two
experiments using whole spleen from alum challenged animals and
! '
draining LN from CF A primed animals. These two types of lymphoid
organs gave the most consistent responses for the adjuvants used.
The opposite combinations (LN from alum primed mice and spleen
from CF primed mice) gave similar results to those shown when
there was a proliferative response in the normal mice. Other
proliferation experiments were done using B cell depleted (on anti-
coated plates) spleen or LNs with mitomycin c treated unprimed
spleen as a source of APC. In these experiments the levels of
proliferation are lower but the overall pattern of the response is the
same. There is a consistent low level of proliferation in the anti-
tolerant cells. This proliferation is very low or absent in the alum
primed mice and greater in the CF primed mice.
There is no evidence that I have activated a proliferating
population of cells which do not help antibody production. There is
very little antigen specific proliferation in the tolerant mice.
uvants. Although most of our tolerance induction has been
tested with alum precipitated challenge, we wanted to know if mIce
were still tolerant after challenge with other adjuvants since
different adjuvants may stimulate different subsets of T cells (117
118). We treated animals with Fab anti-o and then after seven days
challenged them with 100 ~g Fab NRG either precipitated in alum, or
precipitated in alum plus 2 x 108 B. pertussis (both injected i.p.), or
emulsified in CFA and injected s.c. at the base of the tail. As shown
in Figure 16 and Table 12, the alum challenged animals with 
III
..,
ALUM-PRIMED SPLEEN PROLIFERATION
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FIGURE 14. Two experiments showing in vitro proliferation as
measured by cpm of whole spleen cells from alum primed mice. This
figure compares normal mice (black) to mice made tolerant (hatched)
by Lv. treatment with 100 ~g Fab anti-o seven days before challenge
with 100 ~g Fab NRG precipitated in alum. After nine days, spleens
were removed and whole cells were plated at the concentrations
shown with 50 (on the left) or 100 (on the right) ~g F(ab)'2 NRG/ml
added. The cultures were incubated for 96 hours and pulsed for the
last six hours.
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CFA-PRIMED LYMPH NODE PROLIFERATION
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Figure 15. Two experiments showing in vitro proliferation of whole
LN from CF A primed mice. Comparing normal mice (black) to mice
made tolerant (hatched) as described in the previous figure. These
mice were challenged with CFA s.c. All other conditions were the
same as in the previous figure except that the responses of Exp#1
were done at 72 hours instead of 96 hours.
TABLE 
IN VITRO PROLIFERATION
EXPI NORM NORM DELTA TOL TOL DELTA
CELL#I AG NONE NORM NONE TOL
:,,
ALUM
#1/2/50 22205 13642 8563 10197 9178 1019
#1/4/50 45142 35028 10114 21890 24199 2309
#2/4/50 38677 15169 23508 14202 12592 1610
#2/8/50 46877 21458 25419 29721 28080 1641
#1/2/100 36868 13 642 23226 15219 9178 6041
#1/4/100 57410 35028 22382 23845 24199 354
#2/4/1 00 28241 15169 13072 12830 12592 238
#2/8/1 00 48707 21458 27249 30330 28080 2250
CFA LN
#1/2/50 28232 10332 17900 10888 12240 1352
#1/4/50 63983 34385 29598 20998 27218 6220
#2/4/50 18083 5226 12857 4312 1474 2838
#2/8/50 26210 10711 15499 16891 7772 9119
#1/2/100 47280 10332 36948 19470 12240 7230
#1/4/100 77267 34385 42882 44520 27218 17302
#2/4/1 00 16205 5226 10979 2811 1474 1337
#2/8/1 00 18640 10711 7929 16095 7772 8323
TABLE 11. Proliferation in cpm of two experiments. Shown at the
top are whole spleens from normal (untreated) or tolerant (anti-
treated) mice, challenged with 100 ~g Fab NRG precipitated in alum
with and without antigen (AG/NONE) and the Delta cpm
(Normal/Tolerant). On the bottom are cpm from whole LN in groups
as above but challenged with CFA s.c. In column 1 are listed:
Experiment # (l or 2) Cell # (2,4,or 8 xl05 cells), and antigen
concentration (50 or 100 ~g F(ab)'2 NRG). Shown in bold are the
delta cpm which are plotted in Figures 14 and 15. All data are from
cultures incubated for 96 hours except LN from experiment #1 which
are at 72 hours.
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without B. pertussis remain tolerant. CFA partially breaks tolerance
since anti- treated mice challenged with CFA make 18% of the mean
control response (1156 ~g/ml) at day 35 post challenge. This is
consistent with the proliferative response of CF primed lymph
nodes from anti - treated mice shown above.
Since murine helper T cell subsets, which induce switching to
different Ig isotypes, have been defined in vitro (119), we were
interested to see if there were a different spectrum of isotypes
generated in the residual antibody response of tolerant mice versus
the controls. Individual isotype responses, from the sera shown in
Figure 16, were measured by ELISA with goat anti-mouse isotype
specific antibodies. Antibody concentrations were calculated using
mouse anti-ars antibodies of different isotypes as standards. The
data are presented, in Figure 17 and Table 13, as a percentage of the
whole response, since the anti- treated mice make little antibody at
this time (day 35 post challenge). There is no major difference in the
isotypes of anti-rabbit Fab made in the anti-o treated mice. Although
there are differences in the isotypes produced in mice challenged
with different adjuvants, the predominant isotype in all groups
(whether control or anti- treated) was IgG 1. We also tested the
mice shown in Figures 2 and 6 and found no differences in the Ig
isotypes produced: over 90% of the response at day 35 post challenge
was IgGI in iill groups (data not shown).
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Figure 16. Mean serum anti-rabbit Fab antibody response in 
~g/mlfrom mice treated with Fab anti-o as in Figure 1 and then challenged
after 7 days with 100 Jlg Fab NRG either precipitated in alum alone
or with 2 x 108 B. pertussis Lp. , or emulsified in CFA s.c. All anti-groups contain 6 mice and all control groups contain 4 mice each.Bars represent one standard deviation.
TABLE
CHALLENGE WITH DIFFERENT ADJUVANTS
PRE DAY DAY DAY DAY
# 1 1.7
-""
1.4
' - -
1 1
3.4 4.4 7.4
3.4
ALUM!1i 15. 23.
1.28 12. 17.
# 11 1.1 1.3
#12
# 13 0.4 0.4 1.5
#14 1.1
#15 1.1
#16 1.3 1. 7
PERT!1i 1.37
1. 06 10.
#21 110
#22 272 168 114
#23 196 392
#24 1.1 205 231
#26 1.2 202
CF A! 14. 89. 147. 209.
25. 103. 59. 114.
#31 261 789 943 985
#32 441 1276 1122 1161
#33 142 501 636 807
#34 240 749 697 624
ALUM!CONT 271.00 828. 849. 894.
124. 324. 224. 230.
#41 550 1234 1433 1440
#42 473 1605 1611 1824
#43 0.4 360 1824 1582 1556
#44 259 1097 1152 1317
PERT!CONT 410. 1440. 1444. 1534.
127. 334. 210. 216.
#51 " 103 357 494 909
#52 142 378 840 1712
#53 125 400 679 1149
#54 119 535 807 854
CFA!CONT 122. 417. 705. 1156.
16. 80. 156. 392.











































